ORIFARM SUPPLY A/S: Financial statements 2024
CVR: 17153684
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
ORIFARM SUPPLY A/S (CVR 17153684) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 10,456,149,000 and a net result of DKK 269,398,000 compared with DKK 217,497,000 the year before. That is an increase of 19.5% compared with the year before. The profit margin was 2.6%. Equity in the 2024 report amounted to DKK 1,178,008,000. The solvency ratio was 43.9%. The company had 144 employees in the financial year.
- Revenue
- DKK 10,456,149,000
- Gross Profit
- DKK 581,176,000
- Profit/Loss
- DKK 269,398,000
- Equity
- DKK 1,178,008,000
- Total Assets
- DKK 2,682,167,000
- Employees
- 144
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 10.5B | 581.2M | 269.4M | 1.2B | 144 |
| 2023 | 8.7B | 499.6M | 217.5M | 908.6M | 144 |
| 2022 | 8.2B | 349.9M | 154.2M | 691.1M | 138 |
| 2021 | 8B | 342.5M | 173.6M | 712M | 127 |
| 2020 | 7B | 301.7M | 173.5M | 546.7M | 109 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
ORIFARM SUPPLY A/S has published its annual report for 2023. Revenue came to DKK 8,746,302,000, and the net result was DKK 217,497,000.
About ORIFARM SUPPLY A/S
ORIFARM SUPPLY A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 1993. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MEDIPACK A/S and SBH2 ApS. The management consists of Mads Fink Eriksen. The board consists of Ole Michael Friis (chair), Birgitte Bøgh-Sørensen, Hans Carl Bøgh-Sørensen and Nicki Lund Kristensen. The company is owned by MEDIPACK HOLDING A/S. The company has 188 employees (2026). In 2025, the company reported revenue of DKK 11,714,817,000 and a net result of DKK 253,440,000 compared with DKK 269,398,000 the year before. Equity in the 2025 report amounted to DKK 1,337,548,000.
